We have demonstrated that the synthesis of cDNA by avian myeloblastosis virus and Moloney murine leukemia virus reverse transcriptases can be prevented by oligonucleotides bound to the RNA template =100 nucleotides remote from the 3' end of the primer. The RNA was truncated at the level of the antisense oligonucleotide-RNA duplex during the reverse transcription. The key role played by the reverse transcriptase-associated RNase H activity in the inhibition process was shown by the use of (i) inhibitors of RNase H (NaF or dAMP), (it) Moloney murine leukemia virus reverse transcriptase devoid of RNase H activity, or (iii) a-analogues of oligomers that do not elicit RNase H-catalyzed RNA degradation. In all three cases the inhibitory effect was either reduced (NaF, dAMP) or totally abolished. However, an a-oligomer bound to the sequence immediately adjacent to the primerbinding site prevented reverse transcription. Therefore, initiation of polymerization can be blocked by means of an RNase H-independent mechanism, whereas arrest of a growing cDNA strand can be achieved only by an oligonucleotide mediating cleavage of the template RNA.nucleotide inhibited syncytia formation, human immunodeficiency virus protein synthesis, or RT activity was not elucidated.We anticipated that the production of cDNA by retroviral polymerase could be inhibited by an oligonucleotide bound to the RNA downstream from the primer: the RT molecule traveling on the template would be blocked by the hybrid formed between the RNA and the antisense oligonucleotide ( Fig. 1). In a preliminary report we showed that an unmodified 17-mer, indeed, arrested cDNA synthesis by AMV RT (13). We present here a detailed analysis of the effect of antisense oligonucleotides on DNA polymerization by AMV and MMLV RTs. We have been able to demonstrate that the RNase H activity ofAMV and MMLV enzymes was involved in the process because a truncated RNA template was produced. a-Oligomers that are nuclease-resistant analogues of oligonucleotides (14,15) Since the use of synthetic oligonucleotides to inhibit the in vitro development of Rous sarcoma virus (5), the potential therapeutic interest of the antisense strategy has been recognized (6). The emergence of AIDS and the need for different approaches to control retroviruses have led to numerous studies in the field. The antiviral efficiency of both unmodified and modified antisense oligomers has been tested (7-12). Successful results have been reported with oligomers targeted to different sites of viral RNA or mRNA. However, in most cases, the mechanism by which the antisense oligo-MATERIALS AND METHODS Oligonucleotides. Unmodified ,8-and a-oligodeoxynucleotides listed in Table 1 were synthesized either on a Pharmacia or on a Biosearch automatic synthesizer. According to previous studies a-oligomers were designed to bind in a parallel orientation with respect to the RNA strand (16,17). Oligonucleotides linked at their 5' end to 2-methoxy-6-chloro-9-aminoacridine through a pentamethylene linker were prepared...